» Articles » PMID: 31124456

Applying WCACG Modified Process is Beneficial on Reduced Door-to-balloon Time of Acute STEMI Patients

Overview
Date 2019 May 25
PMID 31124456
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Various systems have employed with the objective to reduce the time from emergency medical services contact to balloon inflammation for ST-elevation myocardial infraction (STEMI) patients. The WCACG message system was used to an alternative communication platform to improve confirmation of the diagnosis and movement to treatment, resulted in shorten the door-to-balloon (D-to-B) time for STEMI patients.

Methods: We collected 366 STEMI patients admitted at the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Department of Cardiology, during the period from June 2013 to October 2015. The patients were divided into two groups one underwent the current GC processes and the other group was handled using WCACG system. We compared between two groups with several indicators including D-to-B time, duration of hospitalization, associated costs, and incidence of adverse cardiovascular events.

Results: The results show that the new method with WCACG system significantly reduced the average D-to-B time (from 100.42 ± 25.14 mins to 79.81 ± 20.51 mins, P < 0.05) compared to the GC processes, and also reduced the duration, costs and undesirable cardiac incidence during hospitalization.

Conclusions: The modified WCACG process is an applicable system to save pieces of time and efficiently integrate the opinions of experts in emergency.

Citing Articles

Optimizing Door-to-Balloon Time for Patients Undergoing Primary Percutaneous Coronary Intervention at King Abdullah Medical City.

Elhihi E, Alasmari F, Abdel Rahman O, Almoallad F, Alsalhi R, Alosaimi S Nurs Res Pract. 2024; 2024:9823144.

PMID: 39247450 PMC: 11380713. DOI: 10.1155/2024/9823144.

References
1.
Cannon C, Gibson C, LAMBREW C, Shoultz D, Levy D, French W . Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283(22):2941-7. DOI: 10.1001/jama.283.22.2941. View

2.
Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J . Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study.... N Engl J Med. 2000; 343(6):385-91. DOI: 10.1056/NEJM200008103430602. View

3.
Gibler W, Armstrong P, Ohman E, Weaver W, Stebbins A, Gore J . Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Ann Emerg Med. 2002; 39(2):123-30. DOI: 10.1067/mem.2002.121402. View

4.
Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J . Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 2002; 359(9310):920-5. DOI: 10.1016/S0140-6736(02)08022-4. View

5.
Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View